RxDoctor Payments Data

Eric Lovato

Surgical · Banning, CANPI 1194763342

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,930 of the $16,013 with a category attached, or 80.7%. It is spread thinly across 35 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,013in general payments, 2019–2025

Across 559 payments — averaging $28.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$3K
  • AbbVie$2K
  • Novartis$1K
  • Arcutis Biotherapeutics, Inc.$994
  • Johnson & Johnson$862
  • Galderma Laboratories, L.p.$852
  • plus $7K from 29 others

What the payments were for

  • Consulting fees$2,00012%
  • Speaking & faculty fees$5003%
  • Travel & lodging$2191%
  • Food & beverage$12,93081%
  • Education$3642%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,013 in reported general payments places this provider in the 95th percentile of 729 surgical providers in California.

See all surgical providers in California

Medicare billing

Part B allowed, 2024
$71,291
Medicare patients
194
Services billed
1,032

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinonide20$915
Clobetasol Propionate11$776
Ketoconazole41$663
Minoxidil15$307
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet11$305
Mometasone Furoate13$220
Doxycycline Hyclate13$155
Triamcinolone Acetonide15$81

Paid to pharmacies, not to this prescriber.

Other surgical in Banning

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →